Matrilysin (MMP-7) as a significant determinant of malignant potential of early invasive colorectal carcinomas

scientific article published on May 2001

Matrilysin (MMP-7) as a significant determinant of malignant potential of early invasive colorectal carcinomas is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1027173467
P356DOI10.1054/BJOC.2001.1790
P8608Fatcat IDrelease_d26yqgwknjdd7l2gae7gydv4qm
P932PMC publication ID2363635
P698PubMed publication ID11355941
P5875ResearchGate publication ID11981914

P2093author name stringAtomi Y
Matsuoka H
Masaki T
Sakamoto A
Goto A
Abe N
Sugiyama M
P2860cites workPrognostic value of tumor "budding" in patients with colorectal cancerQ72874023
Predictive value of histology at the invasive margin in the prognosis of early invasive colorectal carcinomaQ73649285
Expression and tissue localization of matrix metalloproteinase 7 (matrilysin) in human gastric carcinomas. Implications for vessel invasion and metastasisQ74534951
Matrix metalloproteinase matrilysin (MMP-7) participates in the progression of human gastric and esophageal cancersQ77410279
Association of matrilysin expression with recurrence and poor prognosis in human esophageal squamous cell carcinomaQ78029650
Tumor cell interactions with the extracellular matrix during invasion and metastasisQ28258256
Purification and properties of a small latent matrix metalloproteinase of the rat uterusQ28292337
Purification and characterization of extracellular matrix-degrading metalloproteinase, matrin (pump-1), secreted from human rectal carcinoma cell lineQ28610329
Policy of local excision for early cancer of the colorectumQ34473932
Histopathology and prognosis of malignant colorectal polyps treated by endoscopic polypectomyQ34525898
Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancersQ35356264
Polypectomy or colectomy? Management of 106 consecutively encountered colorectal polypsQ39628546
Endoscopic polypectomy: inadequate treatment for invasive colorectal carcinomaQ40356430
Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression.Q40472696
Matrilysin: an epithelial matrix metalloproteinase with potentially novel functionsQ41053282
beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancerQ42794991
Treatment of carcinoma in adenomasQ44591666
Prognostic factors in colorectal carcinomas arising in adenomas: implications for lesions removed by endoscopic polypectomyQ45033483
Nucleation of biliary cholesterol, arachidonate, prostaglandin E2, and glycoproteins in postmenopausal womenQ46121171
When is endoscopic polypectomy adequate therapy for colonic polyps containing invasive carcinoma?Q69546498
Surgical pathology of endoscopically removed malignant polyps of the colon and rectumQ71091309
Cancer cell morphology at the invasive front and expression of cell adhesion-related carbohydrate in the primary lesion of patients with colorectal carcinoma with liver metastasisQ71579984
P433issue10
P407language of work or nameEnglishQ1860
P304page(s)1317-1321
P577publication date2001-05-01
P1433published inBritish Journal of CancerQ326309
P1476titleMatrilysin (MMP-7) as a significant determinant of malignant potential of early invasive colorectal carcinomas
P478volume84

Reverse relations

cites work (P2860)
Q33518252Analysis of matrix metalloproteinase-7 expression in eutopic and ectopic endometrium samples from patients with different forms of endometriosis
Q35123003Biology of colorectal liver metastases
Q80080223Clinicopathologic and prognostic significance of matrix metalloproteinases in rectal cancer
Q37408842Clinicopathological and biological significance of cripto overexpression in human colon cancer
Q21260397Clinicopathological significance of expression of p-c-Jun, TCF4 and beta-Catenin in colorectal tumors
Q35104008Clinicopathological significance of stromal variables: angiogenesis, lymphangiogenesis, inflammatory infiltration, MMP and PINCH in colorectal carcinomas
Q73689572Coexpression of matrilysin and laminin-5 gamma2 chain may contribute to tumor cell migration in colorectal carcinomas
Q79207843Colorectal Carcinoma Susceptibility and Metastases Are Associated with Matrix Metalloproteinase-7 Promoter Polymorphisms
Q54375519Combined morphologic and molecular classification for predicting lymph node metastasis in early-stage colorectal adenocarcinoma.
Q35144719Dimerumic acid inhibits SW620 cell invasion by attenuating H₂O₂-mediated MMP-7 expression via JNK/C-Jun and ERK/C-Fos activation in an AP-1-dependent manner.
Q53340431Enhanced expression of MMP-7 and MMP-13 in inflammatory bowel disease: a precancerous potential?
Q37840946Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget
Q49403899Expression of matrix metalloproteinase-7 correlates with the invasion of T1 colorectal carcinoma
Q37003874Genetic polymorphisms in the MMP-7 gene and breast cancer survival
Q36099278High levels of serum VEGF and TIMP-1 are correlated with colon cancer liver metastasis and intrahepatic recurrence after liver resection
Q55439053Identification of DNA methylation prognostic signature of acute myelocytic leukemia.
Q41852083Immunohistochemical molecular markers as predictors of curability of endoscopically resected submucosal colorectal cancer
Q34344991Inferring proteolytic processes from mass spectrometry time series data using degradation graphs
Q36996320Is there a genetic signature for liver metastasis in colorectal cancer?
Q39255564Knockdown of MMP-7 inhibits cell proliferation and enhances sensitivity to 5-Fluorouracil and X-ray irradiation in colon cancer cells
Q39914739LPA receptor 2 mediates LPA-induced endometrial cancer invasion
Q45177603MMP-7 as a prognostic marker in colorectal cancer.
Q52714289MMP-7 expression may influence the rate of distant recurrences and disease-specific survival in HPV-positive oropharyngeal squamous cell carcinoma.
Q49594019MMP7 Modulation by Short- and Long-term Radiotherapy in Patients with Rectal Cancer
Q64453689Matrix metalloproteinase 7 is required for tumor formation, but dispensable for invasion and fibrosis in SMAD4-deficient intestinal adenocarcinomas
Q42259293Matrix metalloproteinase-13 is regulated by toll-like receptor-9 in colorectal cancer cells and mediates cellular migration
Q35715788Matrix metalloproteinase-7 as a surrogate marker predicts renal Wnt/β-catenin activity in CKD.
Q38107451Matrix metalloproteinases in cancer: their value as diagnostic and prognostic markers and therapeutic targets
Q40795997Morphologic and molecular events at the invading edge of colorectal carcinomas
Q35785962NOX1 to NOX2 switch deactivates AMPK and induces invasive phenotype in colon cancer cells through overexpression of MMP-7.
Q38093253Novel biomarkers for the prediction of metastasis in colorectal cancer.
Q35955331Peritoneal expression of Matrilysin helps identify early post-operative recurrence of colorectal cancer.
Q38908279Profile of Expression of Genes Encoding Matrix Metallopeptidase 9 (MMP9), Matrix Metallopeptidase 28 (MMP28) and TIMP Metallopeptidase Inhibitor 1 (TIMP1) in Colorectal Cancer: Assessment of the Role in Diagnosis and Prognostication
Q35643502Prognostic significance of matrix metalloproteinase 7 immunohistochemical expression in colorectal cancer: a meta-analysis
Q52873874Protease probes that enable excimer signaling upon scission.
Q48008581Relationship between matrix metalloproteinase-7 and pit pattern in early stage colorectal cancer
Q37650618Roles of LPA in ovarian cancer development and progression
Q36081008Serum MMP7, MMP10 and MMP12 level as negative prognostic markers in colon cancer patients
Q44855281Simultaneous determination of matrix metalloproteinase (MMP)-7, MMP-1, -3, and -13 gene expression by multiplex PCR in colorectal carcinomas
Q47933451Syndecan-2 cytoplasmic domain up-regulates matrix metalloproteinase-7 expression via the protein kinase Cγ-mediated FAK/ERK signaling pathway in colon cancer
Q36613606Tumour budding at the deepest invasive margin correlates with lymph node metastasis in submucosal colorectal cancer detected by anticytokeratin antibody CAM5.2.

Search more.